ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 137 filers reported holding ANAPTYSBIO INC in Q4 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $334,692 | +22.6% | 10,800 | +0.9% | 0.00% | 0.0% |
| Q3 2022 | $272,957 | -25.0% | 10,700 | -27.2% | 0.00% | 0.0% |
| Q1 2022 | $364,000 | -45.8% | 14,700 | -23.8% | 0.00% | -40.0% |
| Q4 2021 | $671,000 | -12.9% | 19,300 | -32.0% | 0.01% | -37.5% |
| Q3 2021 | $770,000 | +4.2% | 28,400 | -0.4% | 0.01% | +14.3% |
| Q2 2021 | $739,000 | +26.1% | 28,500 | +4.8% | 0.01% | +16.7% |
| Q1 2021 | $586,000 | -21.9% | 27,200 | -22.1% | 0.01% | -25.0% |
| Q4 2020 | $750,000 | +123.2% | 34,900 | +53.1% | 0.01% | +100.0% |
| Q3 2020 | $336,000 | -33.7% | 22,800 | +0.4% | 0.00% | -33.3% |
| Q2 2020 | $507,000 | +111.2% | 22,700 | +33.5% | 0.01% | +100.0% |
| Q1 2020 | $240,000 | -0.8% | 17,000 | +14.1% | 0.00% | 0.0% |
| Q4 2019 | $242,000 | – | 14,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |